KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Vir Biotechnology (VIR) Return on Sales (2018 - 2025)

Vir Biotechnology's Return on Sales history spans 8 years, with the latest figure at 0.67% for Q4 2025.

  • For Q4 2025, Return on Sales rose 778.0% year-over-year to 0.67%; the TTM value through Dec 2025 reached 6.39%, up 112.0%, while the annual FY2025 figure was 6.39%, 65.0% up from the prior year.
  • Return on Sales for Q4 2025 was 0.67% at Vir Biotechnology, up from 679.75% in the prior quarter.
  • Across five years, Return on Sales topped out at 1.07% in Q3 2021 and bottomed at 679.75% in Q3 2025.
  • The 5-year median for Return on Sales is 4.57% (2023), against an average of 58.25%.
  • The largest annual shift saw Return on Sales skyrocketed 8590bps in 2022 before it crashed -58996bps in 2025.
  • A 5-year view of Return on Sales shows it stood at 0.64% in 2021, then plummeted by -422bps to 2.06% in 2022, then plummeted by -236bps to 6.91% in 2023, then fell by -22bps to 8.45% in 2024, then surged by 92bps to 0.67% in 2025.
  • Per Business Quant, the three most recent readings for VIR's Return on Sales are 0.67% (Q4 2025), 679.75% (Q3 2025), and 91.4% (Q2 2025).